UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032860
Receipt number R000037470
Scientific Title Palonosetron versus granisetron in combination with fosaprepitant and dexamethasone for TC therapy in patients with gynecologic gancer
Date of disclosure of the study information 2018/06/10
Last modified on 2018/12/20 17:31:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Palonosetron versus granisetron in combination with fosaprepitant and dexamethasone for TC therapy in patients with gynecologic gancer

Acronym

Antiemetic therapy for TC therapy, phase 3 study.

Scientific Title

Palonosetron versus granisetron in combination with fosaprepitant and dexamethasone for TC therapy in patients with gynecologic gancer

Scientific Title:Acronym

Antiemetic therapy for TC therapy, phase 3 study.

Region

Japan


Condition

Condition

gynecologic gancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety anf efficacy of palonosetron or granisetron in combination with fosaprepitant and dexamethasone for TC therapy in patients with gynecologic gancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The proportion of patients with no vomiting and no nausea

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Palonosetron, fosaprepitant and dexamethasone

Interventions/Control_2

Granisetron, fosaprepitant and dexamethasone

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Female pstienst older than 20 y.o
Fistologically confirmed gynecological cancer
No history of administration with chemotherapy
Scheduled to receive TC regimen

Key exclusion criteria

Severe complicatoins or/and brain metastasis
History of convulsive disorder
Gastrointestinal obstruction

Target sample size

240


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Soshi Kusunoki

Organization

Faculty of Medicine, Juntendo University

Division name

Department of Obstetrics and Gynecology

Zip code


Address

Bunkyoku, Tokyo, Japan

TEL

03-3823-3111

Email

skusuno@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Soshi Kusunoki

Organization

Faculty of Medicine, Juntendo University

Division name

Department of Obstetrics and Gynecology

Zip code


Address

Bunkyoku,Tokyo

TEL

03-3823-3111

Homepage URL


Email

skusuno@juntendo.ac.jp


Sponsor or person

Institute

Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 05 Month 31 Day

Date of IRB


Anticipated trial start date

2018 Year 06 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 06 Month 04 Day

Last modified on

2018 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037470


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name